Luxembourg: Additional Third-Country Vaccine Certificates Approved

Key Points  

  • Four additional vaccine certificates will be accepted for travelers arriving from third countries  

Overview  

As of 16 Nov. 2021, the government of Luxembourg will recognize COVID-19 vaccine certificates issued by the authorities of Georgia, Moldova, New Zealand and Serbia. Third-country foreign nationals from these countries will now be permitted to enter Luxembourg regardless of purpose so long as they hold a valid vaccine certificate in addition to an applicable visa or entry document. For a list of other approved vaccine certificates issued in third-countries click here.  

What are the Changes? 

The government of Luxembourg has approved four additional vaccine certificates for the purpose of non-essential travel.  

Looking Ahead 

Continue to check the government of Luxembourg’s website and Envoy’s website for additional information and updates.  


Content in this publication is for informational purposes only and not intended as legal advice, nor should it be relied on as such. For additional information on the issues discussed, consult an attorney at one of the two U.S. Law Firms working with the Envoy Platform or another qualified professional. On non-U.S. immigration issues, consult an Envoy global immigration service provider or another qualified representative.  

Previous Article
Cyprus: Mandatory Vaccine Checks
Cyprus: Mandatory Vaccine Checks

Businesses in Cyprus with more than 10 employees will be required to check European Digital COVID-19 Vaccin...

Next Article
Peru: Instructions for Virtual Vaccination Certificate 
Peru: Instructions for Virtual Vaccination Certificate 

On 16 Nov. 2021, the government of Peru released guidance for obtaining a virtual vaccination certificate.

×

Stay up-to-date on COVID-19's impact on immigration

By submitting this form, you will receive the requested information, as well as occasional related business insights from Envoy. You can unsubscribe at any time. For details, view our Privacy Policy.
!
Thank you for subscribing!
Error - something went wrong!